UW Radiology

MRX MR eXchange Lecture – Yaou Liu, M.D., Ph.D.

 *** MRX – MR eXchange Lecture – Yaou Liu, M.D., Ph.D. ***


Title:  “Differences and similarities of imaging characteristics between neuromyelitis optica and multiple sclerosis”


Speaker:  Yaou Liu, M.D., Ph.D.                                                                                                                                                                                                                    Professor in Neuroradiology
Department of Neurology, Tianjin General Hopital, Tianjin Medical University,                                                                                                      Consultant Radiologist (Neuroradiology)
Radiology Department, Xuanwu Hospital, Capital Medical University


Date:  Friday, September 1, 2017

Time:  9:00-10:00 pm


Yaou Liu was born in 1980 in Beijing, China. He started his medical education in Capital Medical University in Beijing, received a bachelor degree in 2004 and Master degree in 2007. He earned a M.D. in 2007. From 2007 to 2009, he worked as a research fellow in Royal Melbourne Hospital and Howard Florey Institute, Melbourne, Australia, supported by the 2008 Du Pre grant and 2009 McDonald Fellowship, both awarded by the Multiple Sclerosis International Federation (MSIF). He came back to Xuanwu Hospital, Capital Medical University and was promoted as to consultant radiologist in 2009. In 2013, he received a Ph.D. degree from Capital Medical University, Beijing, China. From 2014-2015, he worked as a research scientist in VU medical center. In May 2015, he came back to Beijing, China and worked as a neuroradiologist and associate professor, and the head of M.S. imaging group in Xuanwu Hospital, Capital Medical University. In 2017, he was awarded his second Ph.D. degree from Vrije Universiteit, Amsterdam, the Netherlands.

Dr. Yaou Liu’s main research interest is investigating the structural and functional alterations of both brain and spinal cord as revealed by MRI imaging techniques, and searching for optimal imaging biomarkers to predict clinical disability, improve differential diagnosis, assess therapeutic effect, and predict clinical conversion in NMO and MS. He has authored more than eighty peer-reviewed articles in the NMO/MS field, including publications in journals such as Immunity, Neurology, Radiology, JNNP and Cerebral Cortex in the past five years, and these have been cited more than 600 times.